Pfizer expects to file for full US Food and Drug Administration approval of its Covid-19 vaccine for 16-to-85-year-olds by the end of May, the company said during its first quarter 2021 earning teleconference Tuesday.
“While we are currently distributing our vaccine in the US under an Emergency Use Authorization (EUA), we expect to submit this month a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) seeking full approval for our Covid-19 vaccine for individuals 16 years of age and older,” Pfizer CEO Albert Bourla said in his remarks.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
NPA launches Call Centre to enhance customer service
2 hours -
Environmental health officers charged to enforce air quality laws
2 hours -
NCCE holds dialogue session of Parliamentary Candidates in South Tongu
2 hours -
Federer pays tribute to Nadal for ‘epic career’
2 hours -
Retiring Nadal’s career over after Spain’s Davis Cup defeat
2 hours -
Seychelles-Ghana: Centenary exhibition celebrates Asante Kingdom’s legacy and ties
3 hours -
Nana Kwame Bediako attends Akyempimhene’s funeral; meets Asantehene after his encounter with Dormaahene
3 hours -
Guardiola agrees one-year extension at Man City
3 hours -
6 basic schools in Akosombo benefit from donation of educational materials by BOST
3 hours -
‘EC fully ready for December 7 elections’ – Bossman Asare
3 hours -
Kufuor Breaks Silence: But where was he during Ghana’s crises?
3 hours -
Google reacts angrily to report it will have to sell Chrome
3 hours -
Debt exchange measures stalled Tema-Aflao road project – Road Minister
3 hours -
Op-Ed: The Kremlin’s Media Strategy in Africa: A new front in information warfare
4 hours -
Asante Kingdom: How Otumfuo Agyeman Prempeh I and Nana Yaa Asantewaa shaped the resistance
4 hours